$1.13 Billion is the total value of First Light Asset Management, LLC's 75 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 5.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATRC | Buy | ATRICURE INC | $89,627,000 | +28.3% | 1,364,812 | +35.8% | 7.90% | +58.0% |
| SPNE | Buy | SEASPINE HOLDINGS CORP | $85,190,000 | -3.9% | 7,005,788 | +7.7% | 7.51% | +18.4% |
| MODN | Buy | MODEL N INC | $72,822,000 | -4.8% | 2,707,143 | +6.2% | 6.42% | +17.2% |
| PRTA | Buy | PROTHENA CORPORATION PLC | $67,236,000 | -16.1% | 1,838,548 | +13.3% | 5.93% | +3.3% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $63,709,000 | +4.8% | 1,597,529 | +5.7% | 5.62% | +29.1% |
| CUTR | Buy | CUTERA INC | $53,422,000 | +96.8% | 774,227 | +17.9% | 4.71% | +142.4% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $50,622,000 | -18.3% | 435,305 | +5.7% | 4.46% | +0.6% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $47,771,000 | +0.4% | 717,936 | +5.6% | 4.21% | +23.7% |
| OMCL | Buy | OMNICELL INC | $41,665,000 | -24.3% | 321,762 | +5.5% | 3.68% | -6.7% |
| KROS | Buy | KEROS THERAPEUTICS INC | $35,790,000 | +10.8% | 658,145 | +19.2% | 3.16% | +36.5% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL INC | $31,772,000 | -8.1% | 437,512 | +6.4% | 2.80% | +13.1% |
| ATEC | Buy | ALPHATEC HOLDINGS INC | $31,258,000 | +17.6% | 2,718,120 | +16.9% | 2.76% | +44.9% |
| CDNA | Buy | CAREDX INC | $26,709,000 | -14.1% | 722,073 | +5.6% | 2.36% | +5.8% |
| SIBN | Buy | SI-BONE INC | $24,513,000 | +53.2% | 1,084,634 | +50.6% | 2.16% | +88.7% |
| HCAT | Buy | HEALTH CATALYST INC | $22,439,000 | -30.3% | 858,733 | +5.6% | 1.98% | -14.2% |
| AXGN | Buy | AXOGEN INC | $19,241,000 | -10.1% | 2,423,335 | +6.0% | 1.70% | +10.6% |
| Buy | PARAGON 28 INC | $18,725,000 | +46.4% | 1,118,603 | +54.8% | 1.65% | +80.3% | |
| AXNX | Buy | AXONICS MODULATION TECHNOLOGIES | $17,497,000 | +130.2% | 279,510 | +105.9% | 1.54% | +183.6% |
| KRMD | Buy | REPRO-MED SYSTEMS INC | $17,445,000 | +5.5% | 6,099,820 | +10.6% | 1.54% | +29.9% |
| INSM | Buy | INSMED INC | $17,338,000 | -8.9% | 737,794 | +5.6% | 1.53% | +12.3% |
| BLU | Buy | BELLUS HEALTH INC | $17,140,000 | -8.5% | 2,491,343 | +7.1% | 1.51% | +12.8% |
| PFMT | Buy | PERFORMANT FINANCIAL CORPORATION | $15,699,000 | +33.3% | 5,048,023 | +3.3% | 1.38% | +64.3% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $13,610,000 | -4.2% | 252,086 | +6.2% | 1.20% | +17.9% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS INC | $12,792,000 | +65.1% | 582,767 | +113.6% | 1.13% | +103.2% |
| BVS | New | BIOVENTUS INC | $12,712,000 | – | 901,525 | +100.0% | 1.12% | – |
| OPRX | Buy | OPTIMIZERX CORP | $12,465,000 | -36.0% | 330,546 | +5.3% | 1.10% | -21.3% |
| NGM | Buy | NGM BIOPHARMACEUTICALS INC | $12,454,000 | +23.2% | 816,653 | +43.0% | 1.10% | +51.7% |
| NEO | Buy | NEOGENOMICS INC | $9,792,000 | -62.4% | 805,958 | +5.5% | 0.86% | -53.7% |
| Buy | MAXCYTE INC | $9,237,000 | -26.4% | 1,321,406 | +7.2% | 0.82% | -9.3% | |
| PFE | Buy | PFIZER INC | $7,622,000 | -10.7% | 147,235 | +1.9% | 0.67% | +10.0% |
| GMAB | Buy | GENMAB AS | $5,858,000 | -6.8% | 161,913 | +1.9% | 0.52% | +14.9% |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $4,735,000 | – | 215,039 | +100.0% | 0.42% | – |
| Buy | AKUMIN INC | $4,119,000 | -35.8% | 3,710,385 | +1.2% | 0.36% | -21.1% | |
| NARI | Buy | INARI MEDICAL INC. | $4,113,000 | +1.2% | 45,379 | +1.9% | 0.36% | +24.7% |
| ABCM | Buy | ABCAM PLC | $4,086,000 | -20.9% | 223,386 | +1.9% | 0.36% | -2.7% |
| SIEN | Buy | SIENTRA INC | $3,972,000 | -32.7% | 1,789,359 | +11.3% | 0.35% | -17.3% |
| SLP | Buy | SIMULATIONS PLUS INC | $3,898,000 | +9.8% | 76,453 | +1.9% | 0.34% | +35.4% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $2,883,000 | -44.8% | 411,328 | +6.3% | 0.25% | -32.1% |
| LHCG | Buy | LHC GROUP INC | $2,613,000 | +25.1% | 15,500 | +1.8% | 0.23% | +53.3% |
| MIRO | Buy | MIROMATRIX MEDICAL INC | $2,029,000 | -11.4% | 512,307 | +5.0% | 0.18% | +9.1% |
| JYNT | Buy | THE JOINT CORP | $1,999,000 | -45.1% | 56,498 | +1.9% | 0.18% | -32.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 43 | Q2 2024 | 9.7% |
| NEOGENOMICS INC | 43 | Q2 2024 | 10.6% |
| SANOFI-SYNTHELABO | 41 | Q4 2023 | 1.9% |
| JOHNSON & JOHNSON | 41 | Q4 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 37 | Q4 2023 | 1.6% |
| NOVARTIS AG-SPONSORED ADR | 34 | Q4 2023 | 0.4% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| MODEL N INC | 32 | Q1 2024 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| OptimizeRx Corp | June 10, 2024 | 1,829,074 | 10.0% |
| TELA Bio, Inc.Sold out | June 10, 2024 | 0 | 0.0% |
| Societal CDMO, Inc. | April 09, 2024 | ? | ? |
| KORU Medical Systems, Inc. | February 14, 2024 | 5,158,444 | 11.3% |
| Performant Financial Corp | February 14, 2024 | 9,696,781 | 12.6% |
| PLIANT THERAPEUTICS, INC. | February 14, 2024 | 3,634,510 | 6.1% |
| SI-BONE, Inc. | February 14, 2024 | 2,532,227 | 6.2% |
| Sonendo, Inc. | February 14, 2024 | 5,446,491 | 10.0% |
| Miromatrix Medical Inc. | December 07, 2023 | 2,592,022 | 9.4% |
| Orthofix Medical Inc.Sold out | October 30, 2023 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-15 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-08-09 |
| SC 13G/A | 2024-07-10 |
| SC 13G/A | 2024-06-10 |
| SC 13G/A | 2024-06-10 |
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.